πŸ‡ΊπŸ‡Έ FDA
Patent

US 11485958

HSD17B13 variants and uses thereof

granted A61KA61K31/713A61K38/443

Quick answer

US patent 11485958 (HSD17B13 variants and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K31/713, A61K38/443, A61K38/465, A61K47/61